BCL2 and neoplasm: It is likely that an early expansion of the MYC-transformed myeloid leukemia cells is counteracted by MYC-induced apoptosis that is overcome by BCL-XL or BCL-2 expression, resulting in an almost immediate tumor transformation of myeloid CD11b/Gr1-positive cells, subsequently causing AML.